ADIPOQ and type 2 diabetes mellitus: In normal weight individuals, genetically elevated adiponectin was associated with lower odds for T2D in both the fully adjusted model (OR 0.13, 95%CI 0.02–0.73, P-value 0.021) (Fig. 4) and the partially adjusted model (OR 0.16, 95%CI 0.03–0.81, P-value 0.027) (Supplementary Figure S2).